Lilly Kong,
Chief Scientific Officer
Lilly Kong joined PrimeraDx in early 2009 as CSO. PrimeraDx is dedicated to the emerging field of molecular diagnostics. Lilly directs scientific and technical affairs to support the development and commercialization of the novel molecular quantitative multiplex multi-modal diagnostic platform. Prior to joining PrimeraDx, Lilly served as the Vice President of Research and Development at Focus Diagnostics, a wholly owned subsidiary of Quest Diagnostics, managing both molecular and immunological diagnostic products and laboratory services. Lilly is a veterinarian, virologist and molecular biologist by training. She received a D.V.M. from National Taiwan University, an M.S. in Veterinary Microbiology from Auburn University, and had her postdoctoral fellowship training in Hematology at the University of Alabama, Birmingham.
|
|
|
